ChitogenX Inc.
CHGX
Rang in Aktien
#39857
ChitogenX Inc. is a Canadian biologics firm specializing in orthopaedic and... ChitogenX Inc. is a Canadian biologics firm specializing in orthopaedic and sports medicine. The company is dedicated to the research and development of innovative therapeutic technologies designed to improve the success rates of soft tissue repair in sports medicine surgeries. Its product pipeline features several biomaterial-based treatments, including Ortho-R for rotator cuff repair, Ortho-M for meniscus repair, and Ortho-C for articular cartilage repair. Additionally, they are developing Ortho-V to address osteoarthritis healing and ORTHO-T for tendon regeneration. Established in 2015, the company underwent a name change from Ortho Regenerative Technologies Inc. to ChitogenX Inc. in September 2022. It maintains its headquarters in Kirkland, Canada.
Aktienkurs
$0.00365786
Zuletzt synchronisiert: 2025-07-07
Marktkapitalisierung
$293.82K
Veränderung (1 Tag)
-0.43%
Veränderung (1 Jahr)
-28.28%
Land
CA
Handel ChitogenX Inc. (CHGX)
Kategorie
Healthcare
Kursverlauf für ChitogenX Inc. (CHGX)
Höchster Schlusskurs: $0.01 am 2026-10-01
Niedrigster Schlusskurs: $0.46 am 2020-10-01
Niedrigster Schlusskurs: $0.46 am 2020-10-01
Kursverlauf der Aktie von ChitogenX Inc. von 2020 bis 2026
Jährliche Kursentwicklung
| Jahr | Leistung |
|---|---|
| 2026 (TTM) | 0.00% |
| 2025 | -53.93% |
| 2024 | -85.54% |
| 2023 | -64.19% |
| 2022 | -43.64% |
| 2021 | -43.08% |
| 2020 | 0.00% |
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
| Unternehmen | Aktienkurs | Veränderung 1J% | Land |
|---|---|---|---|
| $527.18 | 23.62% |
US
|
|
| $251.29 | 835.90% |
US
|
|
| $137.83 | -3.78% |
AU
|
|
| $890.85 | 9.42% |
NL
|
|
| $758.21 | 7.77% |
CH
|
